Newly Isolated Aromatic Compounds from Ailanthus altissima and Their Anti-inflammatory Activity

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Ailanthus altissima bark is a source of diverse natural products.
• Understanding the chemical constituents and bioactivities of A. altissima is ongoing.
• Aromatic natural products often possess significant therapeutic potential.

Purpose of the Study:

• To isolate and characterize novel aromatic compounds from Ailanthus altissima bark.
• To evaluate the anti-inflammatory potential of the isolated compounds.
• To elucidate the mechanism of action for active compounds.

Main Methods:

• Isolation and purification of compounds using chromatographic techniques.
• Structure elucidation via comprehensive spectral analysis (NMR, MS) and chemical calculations.
• In vitro and in vivo assays to assess anti-inflammatory activity.
• Western blotting and molecular dynamics simulations to investigate signaling pathways.

Main Results:

• Five new aromatic compounds were isolated: two benzoic acid derivatives (1, 2), a benzoquinone analogue (3), and lignan enantiomers [(±)-4].
• Compound 3 demonstrated significant anti-inflammatory properties, reducing proinflammatory factors at 15 μM.
• Inhibition of nuclear factor-kappa B (NF-κB) signaling pathways was identified as a potential mechanism for compound 3's activity.

Conclusions:

• Ailanthus altissima bark yields novel aromatic compounds with notable biological activities.
• Compound 3 is a promising anti-inflammatory agent with potential therapeutic applications.
• The anti-inflammatory effects of compound 3 are partly mediated through the inhibition of NF-κB signaling.